Dare Bioscience, Inc. Operating Lease Right-of-Use Assets
Dare Bioscience, Inc. (DARE) had Operating Lease Right-of-Use Assets of $837.60 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $837.60K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $969.26K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.10M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $824.69K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $837.60K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $969.26K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.10M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $824.69K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $955.65K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.08M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.21M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $1.33M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.45M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.56M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.32M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $182.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $276.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $368.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $457.93K 10-K · filed 2024-03-28 | $458.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $546.00K 10-Q · filed 2022-11-10 | |
| 2019-09-30 | $173.27K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $193.40K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $212.91K 10-Q · filed 2019-05-14 | |
| 2019-01-01 | $232.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |